MG
Metagenomi, Inc. Common Stock
MGX · NASDAQ
$1.10 -1.79% (-$0.02)
1M -10.57%
Market Cap $42.5M
P/E Ratio -
Div. Yield -
ROE 63.65%
Piotroski F-Score Weak
2/9Valuation
78 /100
Cheap P/S 3.14x
P/B 0.38x
P/E N/A
Growth
82 /100
Growing Rev. growth 13.59%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 74.29%
Net margin 689.20%
Op. margin 741.58%
Quality
1 /100
Poor ROIC 65.88%
ROE 63.65%
ROA 53.81%
Debt
98 /100
Low Debt/Equity 0.34x
Current ratio 4.50x
Int. coverage N/A
Stability
48 /100
Moderate Beta 0.68x
Rev. volatility 108.17%
EPS volatility 24.86%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na MGX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jian Irish
Employees
113
Headquarters
Emeryville
Nadcházející události
10 LIS
Earnings
Upcoming earnings report